Anticancer agent 268 (Compound 4k) is a potential anti-tumor agent. Anticancer agent 268 exhibits anti-proliferative effects against HepG2 cells, with an IC50 of 6.08 µM. Anticancer agent 268 can induce apoptosis and inhibit colony formation and migration of HepG2 cells[1].
Molekulargewicht:
252.72
Formel:
C12H9ClO2S
Target-Kategorie:
Apoptosis
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
